Clinical Records


MT007544 Age: 58 Gender: M Occupation: NA Onset Date: 2020-01-19 \| Admission date: 2020-01-24 Travel history/ Contact history: In China, The patient had no contact with live food markets, people known to have COVID-19 or hospitals Patient Status: Discharged Clinical symptoms and latent days: The patient felt unwell on 2020/1/19, fever on 2020/1/20 and a cough with sputum production on 2020/1/23, fever(38.1°C), heart rate 95 beats/min, and O2 saturation 94% on room aira, A chest x‐ray showed subtle ill‐defined opacities in the middle zones bilaterally and in the left lower zone Clinical tests: Chest x‐ray, CT scan, Full blood examination, Liver function test abnormalities Chronic Medical Illness: Type 2 diabetes mellitus, and he had ceased smoking four years previously Co-infection with other respiratory pathogens: No Clinical medication and treatment: Intravenous ceftriaxone (2 g/day) and azithromycin (500 mg/day) were commenced on admission day 4 to treat potential secondary bacterial pneumonia, although no bacterial pathogen was identified. Low‐flow oxygen (maximum 3 L/min via nasal prongs) was admi Physiological and biochemical indicators: Lymphocyte count, C‐reactive protein concentration, alkaline phosphatase, γ‐glutamyltransferase, alanine aminotransferase, hepatic steatosis was evident on liver ultrasound Discharge date: 2020-02-07 Sources: Isolation and rapid sharing of the 2019 novel coronavirus (SAR-CoV-2) from the first patient diagnosed with COVID-19 in Australia. Med J Aust
NMDC60013084-01 Age: 49 Gender: F Occupation: Retailer in the seafood wholesale market Onset Date: 2019-12-23 \| Admission date: 2019-12-27 Travel history/ Contact history: A frequent visitor to the seafood wholesale market Severity of illness: Serious Patient Status: Recovered and were discharged Clinical symptoms and latent days: The patient got fever (temperature, 37 ℃ to 38 ℃) and cough with chest discomfort on 2019/12/23. Four days after the onset of illness, her cough and chest discomfort worsened, but the fever was reduced Clinical tests: Immunohistochemical analysis, detection of IgM and IgG antiviral antibodies in the serum samples from a patient at two time points Chronic Medical Illness: With no underlying chronic medical conditions Discharge date: 2020-01-16 Sources: A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med
NMDC60013085-01 Age: 61 Gender: M Occupation: NA Onset Date: 2019-12-20 \| Admission date: 2019-12-27 Travel history/ Contact history: A frequent visitor to the seafood wholesale market Severity of illness: Serious Patient Status: Died Clinical symptoms and latent days: The patient was initially reported fever and cough on 2019/12/20, and respiratory distress developed 7 days after the onset of illness and worsened over the next 2 days Clinical tests: Immunohistochemical analysis, detection of IgM and IgG antiviral antibodies in the serum samples from a patient at two time points, Chest Radiographs Sources: A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med
NMDC60013086-01 Age: 32 Gender: M Occupation: NA Onset Date: NA \| Admission date: 2019-12-27 Severity of illness: Serious Patient Status: Recovered and were discharged Clinical tests: Immunohistochemical analysis, detection of IgM and IgG antiviral antibodies in the serum samples from a patient at two time points Discharge date: 2020-01-16 Sources: A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med
GWHABKF00000001 Age: 65 Gender: M Occupation: Vendor at the Huanan Seafood Market Onset Date: 2019-12-15 \| Admission date: 2019-12-18 Travel history/ Contact history: Worked in the market Severity of illness: Serious Patient Status: Hospitalized Clinical symptoms and latent days: The patient had a high fever (39.3 ℃) and cough, with little sputum production at the onset of illness. He had a continuous fever and developed severe shortness of breath 16 days later Clinical tests: Number of white blood cells/Number of neutrophils/Number of lymphocytes/Number of platelets/Prothrombin time/APTT/D-dimer/ALT/Serum potassium/Serum creatine/Procalcitonin Comorbid conditions: Acute respiratory distress syndrome and secondary infections Clinical medication and treatment: Antibiotic therapy, ECMO, Mechanical ventilation Physiological and biochemical indicators: The lymphocyte counts were generally low. The alanine aminotransferase and serum creatine levels were increased Sources: Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl)
GWHABKL00000001 Age: 49 Gender: F Occupation: Fresh seafood market peddlers or deliverymen Onset Date: 2019-12-23 \| Admission date: 2019-12-27 Travel history/ Contact history: A frequent visitor to the seafood wholesale market Severity of illness: Serious Patient Status: Fever, malaise and cough (2020/1/13) Clinical symptoms and latent days: Fever (37.9 ℃) and palpitation Clinical tests: Blood IgM tests,legionella pneumophilia, mycoplasma pneumoniae, chlamydia pneumoniae, respiratory syncytial virus, adenovirus, rickettsia, influenza A virus, influenza B virus, parainfluenza virus Physiological and biochemical indicators: BALF, oral swab, blood(Ab), anal swab, blood(PCR) Sources: A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature
GWHABKK00000001 Age: 32 Gender: M Occupation: Fresh seafood market peddlers or deliverymen Onset Date: 2019-12-19 \| Admission date: 2019-12-29 Travel history/ Contact history: A frequent visitor to the seafood wholesale market Severity of illness: Serious Patient Status: Fever and intermittent cough (2020/1/13) Clinical symptoms and latent days: Fever, cough and dyspnea Clinical tests: Blood IgM tests,legionella pneumophilia, mycoplasma pneumoniae, chlamydia pneumoniae, respiratory syncytial virus, adenovirus, rickettsia, influenza A virus, influenza B virus, parainfluenza virus Physiological and biochemical indicators: BALF, oral swab, blood(Ab), anal swab, blood(PCR) Sources: A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature
GWHABKM00000001 Age: 52 Gender: F Occupation: Fresh seafood market peddlers or deliverymen Onset Date: 2019-12-22 \| Admission date: 2019-12-29 Travel history/ Contact history: A frequent visitor to the seafood wholesale market Severity of illness: Serious Patient Status: Recovered and were discharged Clinical symptoms and latent days: Fever (38.5 ℃), expectoration, malaise and dyspnea Clinical tests: Blood IgM tests,legionella pneumophilia, mycoplasma pneumoniae, chlamydia pneumoniae, respiratory syncytial virus, adenovirus, rickettsia, influenza A virus, influenza B virus, parainfluenza virus Physiological and biochemical indicators: BALF, oral swab, blood(Ab), anal swab, blood(PCR) Sources: A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature
GWHABKN00000001 Age: 40 Gender: M Occupation: Fresh seafood market peddlers or deliverymen Onset Date: 2019-12-22 \| Admission date: 2019-12-28 Travel history/ Contact history: A frequent visitor to the seafood wholesale market Severity of illness: Serious Patient Status: Fever (38.5 ℃), malaise, expectoration and dizziness (2020/1/13) Clinical symptoms and latent days: Fever (38.5 ℃) and expectoration Clinical tests: Blood IgM tests,legionella pneumophilia, mycoplasma pneumoniae, chlamydia pneumoniae, respiratory syncytial virus, adenovirus, rickettsia, influenza A virus, influenza B virus, parainfluenza virus Physiological and biochemical indicators: BALF, oral swab, blood(Ab), anal swab, blood(PCR) Sources: A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature
GWHABKO00000001 Age: 56 Gender: M Occupation: Fresh seafood market peddlers or deliverymen Onset Date: 2019-12-20 \| Admission date: 2019-12-20 Travel history/ Contact history: A frequent visitor to the seafood wholesale market Severity of illness: Serious Patient Status: Fever, malaise, cough and dyspnea (2020/1/13) Clinical symptoms and latent days: Fever, dyspnea and chest tightness Clinical tests: Blood IgM tests,legionella pneumophilia, mycoplasma pneumoniae, chlamydia pneumoniae, respiratory syncytial virus, adenovirus, rickettsia, influenza A virus, influenza B virus, parainfluenza virus Physiological and biochemical indicators: BALF, oral swab, blood(Ab), anal swab, blood(PCR) Sources: A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature
GWHABKJ00000001 Age: 61 Gender: M Occupation: Worked in the market Onset Date: 2019-12-20 \| Admission date: 2019-12-27 Travel history/ Contact history: Worked in the market Severity of illness: Critical Patient Status: Died Clinical symptoms and latent days: The patient was with a 7-day history of fever, cough, and dyspnea Clinical tests: Number of white blood cells/Number of neutrophils/Number of lymphocytes/Number of platelets/Prothrombin time/APTT/D-dimer/ALT/Serum potassium/Serum creatine/Procalcitonin Chronic Medical Illness: Chronic liver disease and abdominal myxoma Comorbid conditions: Acute respiratory distress syndrome, secondary infections and septic shock as well as acute kidney injury, and ultimately died of multi-organ failure Clinical medication and treatment: CRRT, Antibiotic therapy, ECMO, Mechanical ventilation Physiological and biochemical indicators: BALF, sanger sequencing with specific primers and one-step real-time polymerase chain reaction (RT-PCR) Kit, CXR Sources: Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl)
GWHABKI000000001 Age: 52 Gender: F Occupation: NA Onset Date: 2019-12-22 \| Admission date: 2019-12-29 Travel history/ Contact history: No market exposure Severity of illness: Serious Patient Status: Discharged Clinical symptoms and latent days: Fever(37.5 ℃), cough, and groundglass opacity in the chest computed tomography scan Clinical tests: Number of white blood cells/Number of neutrophils/Number of lymphocytes/Number of platelets/Prothrombin time/APTT/D-dimer/ALT/Serum potassium/Serum creatine/Procalcitonin Clinical medication and treatment: Antibiotic therapy, Nasal cannula Physiological and biochemical indicators: The lymphocyte counts were generally low. The alanine aminotransferase and serum creatine levels were increased Discharge date: 2020-01-08 Sources: Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl)
GWHABKH00000001 Age: 41 Gender: M Occupation: NA Onset Date: 2019-12-16 \| Admission date: 2019-12-22 Travel history/ Contact history: No market exposure Severity of illness: Serious Patient Status: Hospitalized Clinical symptoms and latent days: High fever(39 ℃) and dry cough at the onset of the illness. He developed acute respiratory distress syndrome 7 days later Clinical tests: Number of white blood cells/Number of neutrophils/Number of lymphocytes/Number of platelets/Prothrombin time/APTT/D-dimer/ALT/Serum potassium/Serum creatine/Procalcitonin Chronic Medical Illness: Hypertension Comorbid conditions: Acute respiratory distress syndrome Clinical medication and treatment: Antibiotic therapy, Non-invasive ventilation Physiological and biochemical indicators: The lymphocyte counts were generally low. The alanine aminotransferase and serum creatine levels were increased Sources: Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl)
GWHABKG00000001 Age: 49 Gender: F Occupation: Worker in the Huanan Seafood Market Onset Date: 2019-12-22 \| Admission date: 2019-12-27 Travel history/ Contact history: Worked in the market Severity of illness: Serious Patient Status: Hospitalized Clinical symptoms and latent days: High fever(38.5 ℃) and dry cough. Five days later, she developed dyspnea Clinical tests: BALF and cultured virus, Number of white blood cells/Number of neutrophils/Number of lymphocytes/Number of platelets/Prothrombin time/APTT/D-dimer/ALT/Serum potassium/Serum creatine/Procalcitonin Comorbid conditions: Acute respiratory distress syndrome Clinical medication and treatment: Antibiotic therapy, HFNC Physiological and biochemical indicators: The lymphocyte counts were generally low. The alanine aminotransferase and serum creatine levels were increased Sources: Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl)
EPI_ISL_403962 Age: 60 Gender: F Occupation: NA Onset Date: 2020-01-05 \| Admission date: 2020-01-08 Travel history/ Contact history: The patient went to a local health facility in China and received undisclosed medication on 2020/1/5. She had not visited the Huanan Seafood Market but she was living near another local market, which she visited daily until illness onset Patient Status: Fever (38.6 ℃), a runny nose, sore throat, no dyspnea, no diarrhoea Clinical symptoms and latent days: Fever with chills, sore throat and headache on 2020/1/5, and fever (38.6 ℃) on 2020/1/8 Clinical tests: complete blood /respiratory tract secretions /sputum /inconspicuous lung sounds /CXR /a conventional nested RT-PCR Chronic Medical Illness: Upon admission, her vital signs were normal except for elevated blood pressure Physiological and biochemical indicators: Conventional nested RT-PCR, CXR, complete blood count Discharge date: 2020-01-18 Sources: Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020. Euro Surveill
EPI_ISL_403963 Age: 70 Gender: F Occupation: NA Onset Date: 2020-01-13 \| Admission date: 2020-01-13 Travel history/ Contact history: The patient had recently traveled from Wuhan, She did not visit the Huanan Seafood Market or other markets. She also reported no contact with pigs, camels, other mammals (or areas with dead birds), or any consumption of raw or undercooked foods. She state Patient Status: Fever(38 ℃), mild tachypnoea, CXR was compatible with pneumonia Clinical symptoms and latent days: Fever(38 ℃), a sore throat, cough for an undetermined period Clinical tests: CXR /a conventional nested RT-PCR Physiological and biochemical indicators: Conventional nested RT-PCR, CXR, complete blood count Discharge date: 2020-01-17 Sources: Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020. Euro Surveill
EPI_ISL_407193 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Patient Status: The patient had self-administered antipyretics for initial symptoms such as chills and fever. The patient had experienced intermittent coughing with sputum 3 days after the administration of antipyretics Clinical symptoms and latent days: Chills, fever, intermittent coughing with sputum Clinical tests: Nasopharyngeal and oropharyngeal swab and sputum samples were collected from symptomatic patients to detect SARS-CoV-2 by real-time reverse transcriptase (RT)-PCR Clinical medication and treatment: Self-administered antipyretics Sources: Identification of Coronavirus Isolated from a Patient in Korea with COVID-19. Osong Public Health Res Perspect
LC522975 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Clinical tests: Throat swabs or sputum Sources: Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Natl Acad Sci U S A
MT072688 Age: 32 Gender: M Occupation: Nepalese student at Wuhan University of Technology in Wuhan, China Onset Date: NA \| Admission date: NA Travel history/ Contact history: The patient had returned to Nepal after traveling to Wuhan, China Severity of illness: Serious Patient Status: Cough, mild fever, and throat congestion Clinical symptoms and latent days: Cough, mild fever, and throat congestion Clinical tests: An oropharyngeal swab specimen was collected at the National Influenza Centre, National Public Health Laboratory in Kathmandu, Nepal, and submitted to the WHO laboratory at the University of Hong Kong, Hong Kong Special Administrative Region, China, where it was confirmed and sequenced Chronic Medical Illness: With no history of comorbidities Comorbid conditions: With no history of comorbidities Physiological and biochemical indicators: An oropharyngeal swab specimen tested positive for SARS-CoV-2 by real-time reverse transcriptase PCR (rRT-PCR) developed in the University of Hong Kong Sources: Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal. Microbiol Resour Announc
MN908947 Age: 41 Gender: M Occupation: Worker of seafood market in Wuhan Onset Date: 2019-12-20 \| Admission date: 2019-12-26 Travel history/ Contact history: Work at a local indoor seafood market Patient Status: Admitted to ICU after 3 days of treatment Clinical symptoms and latent days: The patient has fever(38.4 ℃), cough, sputum production, dizzy, weakness, chess tightness, dyspnoea. Chest radiographs were abnormal with air-space shadowing such as ground-glass opacities, focal consolidation and patchy consolidation in both lungs. Computed-tomography scans of the chest revealed bilateral focal consolidation, lobar consolidation and patchy consolidation, especially in the lower lung. A chest radiograph revealed a bilateral diffuse patchy and fuzzy shadow on day 5 after admission (day 11 af Clinical tests: Complete blood count test, blood chemistry tests, arterial blood gas test, chest radiographs, PCR, BALF, deep meta-transcriptomic sequencing Chronic Medical Illness: With no history of hepatitis, tuberculosis or diabetes Co-infection with other respiratory pathogens: negative Bacterial culture Clinical medication and treatment: Glucocorticoid therapy, Antibiotic therapy, Antiviral therapy, Oxygen therapy Physiological and biochemical indicators: Mild lymphopoenia (defined as less than 9 × 105 cells per ml). Elevated levels of C-reactive protein (41.4 mg l−1 of blood. Reference range, 0–6 mg l−1). Mild hypoxaemia with oxygen levels of 67 mm Hg Sources: A new coronavirus associated with human respiratory disease in China. Nature
MN938384 Age: 66 Gender: M Occupation: Retired Onset Date: 2020-01-04 \| Admission date: 2020-01-10 Travel history/ Contact history: The patient flew from Shenzhen to Wuhan on 2019/12/29, and flew back to Shenzhen on 2020/1/4, no history of contact with animals, visits to markets including the Huanan seafood wholesale market in Wuhan, or eating game meat in restaurants. Patient Status: Remained stable as of 2020/1/20 Clinical symptoms and latent days: Fever(39.0 ℃), dry cough, generalised weakness and 96%Oximetry saturation Clinical tests: Haematological, biochemical, and microbiological investigation,CT scan, RT-PCR Chronic Medical Illness: Hypertension Co-infection with other respiratory pathogens: No Physiological and biochemical indicators: Haemoglobin, White blood cell count, Neutrophil count, Lymphocyte count , Platelet count, Prothrombin time , Activated partial thromboplastin time , D-dimer, Fibrinogen, C-reactive protein, Alkaline phosphatase, Creatinine, Sodium, Lactate dehydrogenase Sources: A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet
MN975262 Age: 10 Gender: M Occupation: Student Onset Date: 2020-01-04 \| Admission date: 2020-01-11 Travel history/ Contact history: The patient flew from Shenzhen to Wuhan on 2019/12/29, and flew back to Shenzhen on 2020/1/4, no history of contact with animals, visits to markets including the Huanan seafood wholesale market in Wuhan, or eating game meat in restaurants. Severity of illness: Positive without sym Patient Status: Remained stable as of 2020/1/20 Clinical symptoms and latent days: Lung CT scan showd ground-glass pneumonic changes Clinical tests: Haematological, biochemical, and microbiological investigation,CT scan, RT-PCR Chronic Medical Illness: With no history of comorbidities Co-infection with other respiratory pathogens: No Physiological and biochemical indicators: Haemoglobin, White blood cell count, Neutrophil count, Lymphocyte count , Platelet count, Prothrombin time , Activated partial thromboplastin time , D-dimer, Fibrinogen, C-reactive protein, Alkaline phosphatase, Creatinine, Sodium, Lactate dehydrogenase Sources: A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet
MN985325 Age: 35 Gender: M Occupation: NA Onset Date: 2020-01-15 \| Admission date: 2020-01-20 Travel history/ Contact history: The patient had returned to Washington State on 2020/1/15 after traveling to visit family in Wuhan, China, he reported that he had not spent time at the Huanan seafood market and reported no known contact with ill persons during his travel to China Patient Status: As of 2020/1/30, the patient remains hospitalized. He is afebrile, and all symptoms have resolved with the exception of his cough, which is decreasing in severity Clinical symptoms and latent days: The physical examination revealed a body temperature of 37.2 ℃, blood pressure of 134/87 mm Hg, pulse of 110 beats per minute, respiratory rate of 16 breaths per minute, and oxygen saturation of 96% while the patient was breathing ambient air (2020/1/19). Lung auscultation revealed rhonchi, and chest radiography was performed, which was reported as showing no abnormalities. The patient continued to report a nonproductive cough and appeared fatigued. On the afternoon of hospital day 2, the patient passed a l Clinical tests: On 2020/1/19, a rapid nucleic acid amplification test (NAAT) for influenza A and B was negative. A nasopharyngeal swab specimen was obtained and sent for detection of viral respiratory pathogens by NAAT. This was reported back within 48 hours as negative for all pathogens tested, including influenza A and B, parainfluenza, respiratory syncytial virus, rhinovirus, adenovirus, and four common coronavirus strains known to cause illness in humans (HKU1, NL63, 229E, and OC43). On 2020/1/20, the CDC confirmed tha Chronic Medical Illness: Apart from a history of hypertriglyceridemia, the patient was an otherwise healthy nonsmoker Co-infection with other respiratory pathogens: No Comorbid conditions: No Clinical medication and treatment: For symptom management, the patient received antipyretic therapy consisting of 650 mg of acetaminophen every 4 hours and 600 mg of ibuprofen every 6 hours. He also received 600 mg of guaifenesin for his continued cough and approximately 6 liters of normal Physiological and biochemical indicators: White-cell count, Red-cell count, Absolute neutrophil count, platelet count, Hemoglobin, Calcium, creatinine, etc. Sources: First Case of 2019 Novel Coronavirus in the United States. N Engl J Med
MT020781 Age: 30 Gender: F Occupation: Onset Date: 2020-01-26 \| Admission date: 2020-01-28 Travel history/ Contact history: She left Wuhan on 2020/1/22 and arrived in Finland on 2020/1/23 Severity of illness: Mild Patient Status: The patient was tested PCR-negative in 3 and 4 February samples and, as considered asymptomatic, discharged from hospital on 2020/2/5 Clinical symptoms and latent days: The patient presented mild symptoms without pneumonia: runny nose, nausea, high fever (39 °C) , cough, muscular weakness and fatigue. SARS-CoV-2 infection was confirmed from nasopharyngeal samples on 2020/1/29 by the Helsinki University Hospital Laboratory (HUSLAB), and further confirmed at the Finnish Institute for Health and Welfare (THL) Physiological and biochemical indicators: Both laboratories performed real-time RT-PCR testing for three targets: the envelope (E), the RNA-dependent RNA polymerase (RdRp) and the nucleocapsid (N) IgM,IgG (Serum samples ) Discharge date: 2020-02-05 Sources: Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020. Euro Surveill
MT020880 Age: 35 Gender: M Occupation: NA Onset Date: 2020-01-20 \| Admission date: 2020-01-20 Travel history/ Contact history: Traveled to China Patient Status: As of 2020/1/30, the patient remains hospitalized. He is afebrile, and all symptoms have resolved with the exception of his cough, which is decreasing in severity Clinical symptoms and latent days: The physical examination revealed a body temperature of 37.2 ℃, blood pressure of 134/87 mm Hg, pulse of 110 beats per minute, respiratory rate of 16 breaths per minute, and oxygen saturation of 96% while the patient was breathing ambient air (2020/1/19). Lung auscultation revealed rhonchi, and chest radiography was performed, which was reported as showing no abnormalities. The patient continued to report a nonproductive cough and appeared fatigued. On the afternoon of hospital day 2, the patient passed a l Clinical tests: Both NP and OP swab specimens were used for virus isolation; Standard plaque assays were used for SARS-CoV-2, which were based on SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV) protocols; Fast Track Respiratory Pathogens 33 Testing (FTD Diagnostics) was performed for 33 additional different respiratory pathogens. Chronic Medical Illness: Apart from a history of hypertriglyceridemia, the patient was an otherwise healthy nonsmoker Co-infection with other respiratory pathogens: No Comorbid conditions: No Clinical medication and treatment: For symptom management, the patient received antipyretic therapy consisting of 650 mg of acetaminophen every 4 hours and 600 mg of ibuprofen every 6 hours. He also received 600 mg of guaifenesin for his continued cough and approximately 6 liters of normal Physiological and biochemical indicators: White-cell count, Red-cell count, Absolute neutrophil count, platelet count, Hemoglobin, Calcium, creatinine, etc. Sources: Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States. Emerg Infect Dis
MT020881 Age: 35 Gender: M Occupation: NA Onset Date: 2020-01-20 \| Admission date: 2020-01-20 Travel history/ Contact history: Traveled to China Patient Status: As of 2020/1/30, the patient remains hospitalized. He is afebrile, and all symptoms have resolved with the exception of his cough, which is decreasing in severity Clinical symptoms and latent days: The physical examination revealed a body temperature of 37.2 ℃, blood pressure of 134/87 mm Hg, pulse of 110 beats per minute, respiratory rate of 16 breaths per minute, and oxygen saturation of 96% while the patient was breathing ambient air (2020/1/19). Lung auscultation revealed rhonchi, and chest radiography was performed, which was reported as showing no abnormalities. The patient continued to report a nonproductive cough and appeared fatigued. On the afternoon of hospital day 2, the patient passed a l Clinical tests: Both NP and OP swab specimens were used for virus isolation; Standard plaque assays were used for SARS-CoV-2, which were based on SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV) protocols; Fast Track Respiratory Pathogens 33 Testing (FTD Diagnostics) was performed for 33 additional different respiratory pathogens. Chronic Medical Illness: Apart from a history of hypertriglyceridemia, the patient was an otherwise healthy nonsmoker Co-infection with other respiratory pathogens: No Comorbid conditions: No Clinical medication and treatment: For symptom management, the patient received antipyretic therapy consisting of 650 mg of acetaminophen every 4 hours and 600 mg of ibuprofen every 6 hours. He also received 600 mg of guaifenesin for his continued cough and approximately 6 liters of normal Physiological and biochemical indicators: White-cell count, Red-cell count, Absolute neutrophil count, platelet count, Hemoglobin, Calcium, creatinine, etc. Sources: Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States. Emerg Infect Dis
MT039890 Age: 35 Gender: F Occupation: NA Onset Date: 2019-01-18 \| Admission date: 2019-01-19 Travel history/ Contact history: The patient arrived at the Incheon airport from Wuhan on 2020/1/19 Patient Status: Developed fever, chill, and myalgia. Developed nasal congestion, cough, and sputum the next day. Fever persisted for ten days and her maximum body temperature during her illness was 38.9 °C on day 7 of illness Clinical symptoms and latent days: The patient developed fever, chill, and myalgia on 2020/1/18. After laboratory-confirmed diagnosis of SARS-CoV-2 infection, she developed nasal congestion, cough, and sputum. Oxygen supplementation was started on day 4 of her illness, and her oxygen requirement increased to 6 L/min on day 7 of illness. Fever persisted for ten days and her maximum body temperature during her illness was 38.9 °C on day 7 of illness Clinical tests: Oropharyngeal samples Sources: Virus Isolation from the First Patient with SARS-CoV-2 in Korea. J Korean Med Sci
CNA0007332 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: The patient had visited to the seafood wholesale market Clinical tests: BALF Sources: Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet
CNA0007333 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: The patient had visited to the seafood wholesale market Clinical tests: BALF Sources: Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet
CNA0007334 Age: NA Gender: NA Occupation: NA Onset Date: 2019-12-26 \| Admission date: NA Travel history/ Contact history: The patient had visited to the seafood wholesale market Clinical tests: BALF Sources: Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet
CNA0007335 Age: NA Gender: NA Occupation: NA Onset Date: 2019-12-27 \| Admission date: NA Travel history/ Contact history: The patient stayed in a hotel near the seafood wholesale market between 2019/12/23 and 2019/12/27 Clinical symptoms and latent days: Fever Clinical tests: BALF Sources: Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet
NMDC60013002-05 Age: NA Gender: NA Occupation: NA Onset Date: 2019-12-22 \| Admission date: NA Travel history/ Contact history: The patient had visited to the seafood wholesale market Clinical tests: BALF Sources: Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet
NMDC60013002-06 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: 2019-12-29 Travel history/ Contact history: The patient had visited to the seafood wholesale market Clinical tests: BALF Sources: Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet
NMDC60013002-07 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: The patient had visited to the seafood wholesale market Clinical tests: Throat swab Sources: Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet
NMDC60013002-08 Age: NA Gender: NA Occupation: NA Onset Date: 2019-12-23 \| Admission date: 2019-12-29 Travel history/ Contact history: The patient had visited to the seafood wholesale market Clinical tests: BALF and cultured virus Sources: Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet
NMDC60013002-09 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: The patient had visited to the seafood wholesale market Clinical tests: BALF Sources: Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet
NMDC60013002-10 Age: NA Gender: NA Occupation: NA Onset Date: 2019-12-23 \| Admission date: 2019-12-29 Travel history/ Contact history: The patient had visited to the seafood wholesale market Clinical tests: BALF and cultured virus Sources: Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet
MT066156 Age: NA Gender: F Occupation: NA Onset Date: 2020-01-29 \| Admission date: 2020-01-29 Clinical symptoms and latent days: Fever and respiratory symptoms Clinical tests: Conventional nested RT-PCR Sources: Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy. Clin Microbiol Infect
EPI_ISL_412974 Age: NA Gender: NA Occupation: NA Onset Date: 2020-01-29 \| Admission date: 2020-01-29 Travel history/ Contact history: A Chinese tourist from Wuhan diagnosed at the end of January, who had visited Rome and not been in areas of Italy later found to be the initially affected areas of the epidemic in Lombardy Severity of illness: Serious Patient Status: Pneumonia, had onset of symptoms on 2020/1/29 and had been diagnosed in a hospital in Rome Clinical symptoms and latent days: The patient had an acute respiratory illness (pneumonia), showing a bilateral lung involvement with ground-glass opacity, requiring intensive care. Clinical tests: Nasopharyngeal swabs testing. Biological samples from patients had been confirmed as being SARS-CoV-2 positive. Sources: Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe. Euro Surveill
EPI_ISL_412973 Age: NA Gender: NA Occupation: NA Onset Date: 2020-02-10 \| Admission date: 2020-02-10 Travel history/ Contact history: No apparent direct epidemiological link with China Severity of illness: Serious Patient Status: Pneumonia, onset of symptoms had occurred on 2020/2/10 and had been diagnosed in a hospital in Milan Clinical symptoms and latent days: The patient had an acute respiratory illness (pneumonia), showing a bilateral lung involvement with ground-glass opacity, requiring intensive care. Clinical tests: Nasopharyngeal swabs testing. Biological samples from patients had been confirmed as being SARS-CoV-2 positive. Sources: Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe. Euro Surveill
EPI_ISL_414934 Age: 62 Gender: F Occupation: NA Onset Date: 2020-01-12 \| Admission date: 2020-01-21 Travel history/ Contact history: The patient traveled to hometown in Xiaogan, Hubei Provience 2019/12/29 to 2020/1/15, and changed trains at the Hankou raileway station in Wuhan Severity of illness: Symptomatic Patient Status: Recovered and were discharged to home isolation for 14 days Clinical symptoms and latent days: The patient got cough, rhinorrhea, and sputum on 2020/1/12. On 2020/1/15, she visited a health clinic and was diagnosed with a common cold. She was prescribed intravenous infusions of ampicillin and sulbactam, ribavirin, and traditional medicine for five days. On 2020/1/16, she developed a fever (38°C). ground-glass opacities Clinical tests: Chest CT images Discharge date: 2020-02-06 Sources: Transmission potential of asymptomatic and paucisymptomatic SARS-CoV-2 infections: a three-family cluster study in China. J Infect Dis
EPI_ISL_414935 Age: 65 Gender: M Occupation: NA Onset Date: 2020-01-17 \| Admission date: 2020-01-21 Travel history/ Contact history: The patient traveled to hometown in Xiaogan, Hubei Provience 2019/12/29 to 2020/1/15, and changed trains at the Hankou raileway station in Wuhan Severity of illness: Symptomatic Patient Status: Recovered and were discharged to home isolation for 14 days Clinical symptoms and latent days: Symptoms of fever (37.8°C), cough, sputum, earache, and upset stomach.ground-glass opacities Clinical tests: Chest CT images Discharge date: 2020-02-09 Sources: Transmission potential of asymptomatic and paucisymptomatic SARS-CoV-2 infections: a three-family cluster study in China. J Infect Dis
EPI_ISL_414936 Age: 37 Gender: M Occupation: NA Onset Date: 2020-01-22 \| Admission date: 2020-01-24 Travel history/ Contact history: No travel to Wuhan and close contacts of Patients 1 and 2 Severity of illness: Symptomatic Patient Status: Recovered and were discharged to home isolation for 14 days Clinical symptoms and latent days: No symptoms on 2020/1/23, a slightly dry and itchy throat. The cough was a major symptom during hospitalization, and two days fever and four days fatigue of the total hospital stay was also recorded.ground-glass opacities Clinical tests: Chest CT images Discharge date: 2020-02-06 Sources: Transmission potential of asymptomatic and paucisymptomatic SARS-CoV-2 infections: a three-family cluster study in China. J Infect Dis
EPI_ISL_414937 Age: 35 Gender: F Occupation: NA Onset Date: 2020-01-22 \| Admission date: 2020-01-27 Travel history/ Contact history: No travel to Wuhan and close contacts of Patients 1 and 2 Severity of illness: Positive without sym Patient Status: Recovered and were discharged to home isolation for 14 days Clinical symptoms and latent days: No identified clinical symptoms, chest CT images showed ground-glass opacities Clinical tests: Chest CT images Discharge date: 2020-02-06 Sources: Transmission potential of asymptomatic and paucisymptomatic SARS-CoV-2 infections: a three-family cluster study in China. J Infect Dis
EPI_ISL_414938 Age: 53 Gender: F Occupation: NA Onset Date: 2020-01-23 \| Admission date: 2020-01-24 Travel history/ Contact history: Close contacts of Patients1-4 Severity of illness: Positive without sym Patient Status: Recovered and were discharged to home isolation for 14 days Clinical symptoms and latent days: The patient did not show any clinical symptoms of infection during hospital,chest CT images showed ground-glass opacities Clinical tests: Chest CT images Discharge date: 2020-02-14 Sources: Transmission potential of asymptomatic and paucisymptomatic SARS-CoV-2 infections: a three-family cluster study in China. J Infect Dis
EPI_ISL_414939 Age: 28 Gender: M Occupation: NA Onset Date: 2020-01-24 \| Admission date: 2020-01-25 Travel history/ Contact history: Close contact of Patient 5 Severity of illness: Symptomatic Patient Status: Recovered and were discharged to home isolation for 14 days Clinical symptoms and latent days: On admission in the afternoon on 2020/1/25, he developed a fever (37.5°C). Major symptoms during hospitalization included fever and cough, and the symptoms persisted more than two weeks, chest CT images showed ground-glass opacities Clinical tests: Chest CT images Discharge date: 2020-02-17 Sources: Transmission potential of asymptomatic and paucisymptomatic SARS-CoV-2 infections: a three-family cluster study in China. J Infect Dis
EPI_ISL_414940 Age: 35 Gender: M Occupation: NA Onset Date: 2020-01-26 \| Admission date: 2020-01-26 Travel history/ Contact history: Close contacts of Patients 3 Severity of illness: Paucisymptomatic Patient Status: Recovered and were discharged to home isolation for 14 days Clinical symptoms and latent days: Paucisymptomatic, with only an occasional cough, chest CT showed on no significant abnormalities Clinical tests: Chest CT images Discharge date: 2020-02-16 Sources: Transmission potential of asymptomatic and paucisymptomatic SARS-CoV-2 infections: a three-family cluster study in China. J Infect Dis
EPI_ISL_414941 Age: 3 Gender: F Occupation: NA Onset Date: 2020-01-26 \| Admission date: 2020-01-27 Travel history/ Contact history: Close contacts of Patients 7 Severity of illness: Positive without sym Patient Status: Recovered and were discharged to home isolation for 14 days Clinical symptoms and latent days: Weak positive on 2020/1/27, posotive on 2020/1/29 no clinical symptoms before, during, or after hospitalization,chest CT showed on no significant abnormalities Clinical tests: Chest CT images Discharge date: 2020-02-16 Sources: Transmission potential of asymptomatic and paucisymptomatic SARS-CoV-2 infections: a three-family cluster study in China. J Infect Dis
EPI_ISL_418260 Age: 41 Gender: M Occupation: NA Onset Date: NA \| Admission date: NA Clinical tests: Conventional nested RT-PCR Sources: A "One-Health" approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy. One Health
EPI_ISL_418259 Age: 76 Gender: M Occupation: NA Onset Date: NA \| Admission date: NA Clinical tests: Conventional nested RT-PCR Sources: A "One-Health" approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy. One Health
EPI_ISL_418257 Age: 75 Gender: F Occupation: NA Onset Date: NA \| Admission date: NA Clinical tests: Conventional nested RT-PCR Sources: A "One-Health" approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy. One Health
EPI_ISL_418256 Age: 80 Gender: M Occupation: NA Onset Date: NA \| Admission date: NA Clinical tests: Conventional nested RT-PCR Sources: A "One-Health" approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy. One Health
EPI_ISL_418255 Age: 63 Gender: F Occupation: NA Onset Date: NA \| Admission date: NA Clinical tests: Conventional nested RT-PCR Sources: A "One-Health" approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy. One Health
EPI_ISL_418258 Age: 87 Gender: M Occupation: NA Onset Date: NA \| Admission date: NA Clinical tests: Conventional nested RT-PCR Sources: A "One-Health" approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy. One Health
EPI_ISL_418261 Age: 78 Gender: F Occupation: NA Onset Date: NA \| Admission date: NA Clinical tests: Conventional nested RT-PCR Sources: A "One-Health" approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy. One Health
EPI_ISL_420563 Age: 68 Gender: M Occupation: NA Onset Date: NA \| Admission date: NA Clinical tests: Conventional nested RT-PCR Sources: A "One-Health" approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy. One Health
EPI_ISL_420564 Age: 54 Gender: M Occupation: NA Onset Date: NA \| Admission date: NA Clinical tests: Conventional nested RT-PCR Sources: A "One-Health" approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy. One Health
EPI_ISL_420565 Age: 61 Gender: M Occupation: NA Onset Date: NA \| Admission date: NA Clinical tests: Conventional nested RT-PCR Sources: A "One-Health" approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy. One Health
EPI_ISL_420566 Age: 71 Gender: M Occupation: NA Onset Date: NA \| Admission date: NA Clinical tests: Conventional nested RT-PCR Sources: A "One-Health" approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy. One Health
EPI_ISL_420568 Age: 43 Gender: M Occupation: NA Onset Date: NA \| Admission date: NA Clinical tests: Conventional nested RT-PCR Sources: A "One-Health" approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy. One Health
EPI_ISL_420592 Age: 29 Gender: F Occupation: NA Onset Date: NA \| Admission date: NA Clinical tests: Conventional nested RT-PCR Sources: A "One-Health" approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy. One Health
EPI_ISL_420567 Age: 64 Gender: M Occupation: NA Onset Date: NA \| Admission date: NA Clinical tests: Conventional nested RT-PCR Sources: A "One-Health" approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy. One Health
EPI_ISL_420569 Age: 86 Gender: M Occupation: NA Onset Date: NA \| Admission date: NA Clinical tests: Conventional nested RT-PCR Sources: A "One-Health" approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy. One Health
EPI_ISL_420583 Age: 38 Gender: M Occupation: NA Onset Date: NA \| Admission date: NA Clinical tests: Conventional nested RT-PCR Sources: A "One-Health" approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy. One Health
MT262896 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT262897 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT262898 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT262899 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT262900 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT262901 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT262902 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT262903 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT262904 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT262905 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT262906 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT262907 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT262908 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT262909 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT262910 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT262911 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT262912 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT262913 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT262914 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT262915 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT262916 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT350264 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT350266 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT350267 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT350263 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT350268 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT350265 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT350276 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT350278 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT350272 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT350273 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT350275 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT350277 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT350279 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT350270 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT350274 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT350280 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT350269 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
MT350271 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A resident of a skilled nursing facility with clusters of cases Clinical tests: Nasopharyngeal swab, oropharyngeal swab and rRT-PCR Sources: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med
LC529905 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: Travelers or returnee from China Clinical symptoms and latent days: Asymptomatic carrier Clinical tests: qRT-PCR Sources: Characteristics of SARS-CoV-2 isolated from asymptomatic carrier in Tokyo. Jpn J Infect Dis
MT374101 Age: NA Gender: M Occupation: NA Onset Date: NA \| Admission date: NA
MT370516 Age: NA Gender: F Occupation: NA Onset Date: NA \| Admission date: NA
MT374102 Age: NA Gender: F Occupation: NA Onset Date: NA \| Admission date: NA
NMDC60013024-01 Age: Gender: Occupation: Onset Date: 2020-01-18 \| Admission date: Travel history/ Contact history: hubei Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013046-01 Age: Gender: Occupation: Onset Date: 2020-01-27 \| Admission date: Travel history/ Contact history: hubei Severity of illness: severe Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013017-01 Age: Gender: Occupation: Onset Date: 2020-01-26 \| Admission date: Travel history/ Contact history: guangdong Severity of illness: critical Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013049-01 Age: Gender: Occupation: Onset Date: 2020-01-24 \| Admission date: Travel history/ Contact history: other Severity of illness: critical Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013030-01 Age: Gender: Occupation: Onset Date: NA \| Admission date: Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013051-01 Age: Gender: Occupation: Onset Date: 2020-01-21 \| Admission date: Travel history/ Contact history: hubei Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013028-01 Age: Gender: Occupation: Onset Date: 2020-01-27 \| Admission date: Travel history/ Contact history: guangdong Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013052-01 Age: Gender: Occupation: Onset Date: 2020-01-21 \| Admission date: Travel history/ Contact history: guangdong Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013044-01 Age: Gender: Occupation: Onset Date: 2020-01-21 \| Admission date: Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013032-01 Age: Gender: Occupation: Onset Date: 2020-01-27 \| Admission date: Travel history/ Contact history: hubei Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013057-01 Age: Gender: Occupation: Onset Date: 2020-02-08 \| Admission date: Travel history/ Contact history: other Severity of illness: mild Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013045-01 Age: Gender: Occupation: Onset Date: 2020-01-24 \| Admission date: Travel history/ Contact history: hubei Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013034-01 Age: Gender: Occupation: Onset Date: 2020-01-22 \| Admission date: Travel history/ Contact history: hubei Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013033-01 Age: Gender: Occupation: Onset Date: 2020-01-29 \| Admission date: Travel history/ Contact history: hubei Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013029-01 Age: Gender: Occupation: Onset Date: 2020-01-25 \| Admission date: Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013053-01 Age: Gender: Occupation: Onset Date: 2020-01-27 \| Admission date: Travel history/ Contact history: guangdong Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013022-01 Age: Gender: Occupation: Onset Date: NA \| Admission date: Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013042-01 Age: Gender: Occupation: Onset Date: 2020-01-21 \| Admission date: Travel history/ Contact history: hubei Severity of illness: severe Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013041-01 Age: Gender: Occupation: Onset Date: 2020-02-01 \| Admission date: Travel history/ Contact history: hubei Severity of illness: critical Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013023-01 Age: Gender: Occupation: Onset Date: 2020-01-21 \| Admission date: Travel history/ Contact history: hubei Severity of illness: severe Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013031-01 Age: Gender: Occupation: Onset Date: 2020-01-27 \| Admission date: Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013047-01 Age: Gender: Occupation: Onset Date: 2020-01-19 \| Admission date: Travel history/ Contact history: hubei Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013050-01 Age: Gender: Occupation: Onset Date: 2020-01-25 \| Admission date: Travel history/ Contact history: hubei Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013048-01 Age: Gender: Occupation: Onset Date: 2020-01-30 \| Admission date: Travel history/ Contact history: hubei Severity of illness: severe Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013055-01 Age: Gender: Occupation: Onset Date: 2020-01-23 \| Admission date: Travel history/ Contact history: guangdong Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013020-01 Age: Gender: Occupation: Onset Date: 2020-01-25 \| Admission date: Travel history/ Contact history: hubei Severity of illness: severe Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013027-01 Age: Gender: Occupation: Onset Date: 2020-01-27 \| Admission date: Travel history/ Contact history: guangdong Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013026-01 Age: Gender: Occupation: Onset Date: 2020-01-29 \| Admission date: Travel history/ Contact history: hubei Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013056-01 Age: Gender: Occupation: Onset Date: 2020-01-28 \| Admission date: Travel history/ Contact history: hubei Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013018-01 Age: Gender: Occupation: Onset Date: 2020-01-28 \| Admission date: Travel history/ Contact history: hubei Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013019-01 Age: Gender: Occupation: Onset Date: 2020-01-24 \| Admission date: Travel history/ Contact history: hubei Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013025-01 Age: Gender: Occupation: Onset Date: 2020-01-30 \| Admission date: Travel history/ Contact history: guangdong Severity of illness: critical Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013021-01 Age: Gender: Occupation: Onset Date: 2020-01-29 \| Admission date: Travel history/ Contact history: hubei Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013054-01 Age: Gender: Occupation: Onset Date: 2020-01-21 \| Admission date: Travel history/ Contact history: hubei Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013043-01 Age: Gender: Occupation: Onset Date: 2020-01-27 \| Admission date: Travel history/ Contact history: hubei Severity of illness: severe Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013035-01 Age: Gender: Occupation: Onset Date: 2020-01-31 \| Admission date: Travel history/ Contact history: hubei Severity of illness: mild Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013036-01 Age: Gender: Occupation: Onset Date: 2020-02-04 \| Admission date: Severity of illness: asymptomatic Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013037-01 Age: Gender: Occupation: Onset Date: 2020-01-22 \| Admission date: Travel history/ Contact history: hubei Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013038-01 Age: Gender: Occupation: Onset Date: 2020-01-21 \| Admission date: Travel history/ Contact history: hubei Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013039-01 Age: Gender: Occupation: Onset Date: 2020-01-30 \| Admission date: Travel history/ Contact history: hubei Severity of illness: severe Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013040-01 Age: Gender: Occupation: Onset Date: 2020-02-08 \| Admission date: Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013058-01 Age: Gender: Occupation: Onset Date: 2020-02-06 \| Admission date: Travel history/ Contact history: hubei Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013059-01 Age: Gender: Occupation: Onset Date: 2020-02-08 \| Admission date: Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013060-01 Age: Gender: Occupation: Onset Date: 2020-01-23 \| Admission date: Travel history/ Contact history: hubei Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013061-01 Age: Gender: Occupation: Onset Date: 2020-02-09 \| Admission date: Travel history/ Contact history: other Severity of illness: mild Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013062-01 Age: Gender: Occupation: Onset Date: 2020-02-01 \| Admission date: Travel history/ Contact history: other Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013063-01 Age: Gender: Occupation: Onset Date: 2020-02-20 \| Admission date: Travel history/ Contact history: guangdong Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013064-01 Age: Gender: Occupation: Onset Date: 2020-01-27 \| Admission date: Travel history/ Contact history: hubei Severity of illness: severe Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013065-01 Age: Gender: Occupation: Onset Date: 2020-01-26 \| Admission date: Travel history/ Contact history: hubei Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013066-01 Age: Gender: Occupation: Onset Date: 2020-01-05 \| Admission date: Travel history/ Contact history: hubei Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013067-01 Age: Gender: Occupation: Onset Date: 2020-02-06 \| Admission date: Travel history/ Contact history: hubei Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013068-01 Age: Gender: Occupation: Onset Date: 2020-02-10 \| Admission date: Travel history/ Contact history: guangdong Severity of illness: moderate Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
NMDC60013069-01 Age: Gender: Occupation: Onset Date: 2020-02-07 \| Admission date: Travel history/ Contact history: guangdong Sources: Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Cell
MT339039 Age: NA Gender: NA Occupation: NA Onset Date: \| Admission date: Clinical tests: Influenza-negative nasopharyngeal (NP)swabs were tested for SARS-CoV-2; extracted total nucleic acid Sources: An 81 nucleotide deletion in SARS-CoV-2 ORF7a identified from sentinel surveillance in Arizona (Jan-Mar 2020). J Virol
MT339040 Age: NA Gender: NA Occupation: NA Onset Date: \| Admission date: Clinical tests: Influenza-negative nasopharyngeal (NP)swabs were tested for SARS-CoV-2; extracted total nucleic acid Sources: An 81 nucleotide deletion in SARS-CoV-2 ORF7a identified from sentinel surveillance in Arizona (Jan-Mar 2020). J Virol
MT339041 Age: NA Gender: NA Occupation: NA Onset Date: \| Admission date: Clinical tests: Influenza-negative nasopharyngeal (NP)swabs were tested for SARS-CoV-2; extracted total nucleic acid Sources: An 81 nucleotide deletion in SARS-CoV-2 ORF7a identified from sentinel surveillance in Arizona (Jan-Mar 2020). J Virol
MT446312 Age: 72 Gender: M Occupation: NA Onset Date: \| Admission date: Travel history/ Contact history: had a history of recent travel to Wuhan Clinical symptoms and latent days: On January 25th, 2020,cough and fever,multiple ground-glass opacities in both lungs,On February 3rd, the patient’s condition deteriorated and he was intubated and put on a ventilator Clinical tests: Computed tomography (CT) scan of the chest,RT-PCR Clinical medication and treatment: On February 3rd, the patient’s condition deteriorated and he was intubated and put on a ventilator Sources: Isolation of Infectious SARS-CoV-2 from Urine of a COVID-19 Patient. Emerg Microbes Infect
EPI_ISL_416473 Age: 53 Gender: M Occupation: NA Onset Date: \| Admission date: Travel history/ Contact history: Live in Wuhan Severity of illness: Critical Patient Status: Recover Clinical symptoms and latent days: Fever,fatigue Clinical tests: Ultra-deep sequencing of the isolated viral genomic RNA(Illumina Novaseq 6000 platform) Discharge date: 2020.02.19
EPI_ISL_416474 Age: 30 Gender: M Occupation: NA Onset Date: \| Admission date: Travel history/ Contact history: Conference with colleagues from Wuhan Severity of illness: Severe Patient Status: Recover Clinical symptoms and latent days: Fever Clinical tests: Ultra-deep sequencing of the isolated viral genomic RNA(Illumina Novaseq 6000 platform) Discharge date: 2020.02.05
EPI_ISL_418990 Age: 38 Gender: F Occupation: NA Onset Date: \| Admission date: Travel history/ Contact history: Live in Wuhan Severity of illness: Severe Patient Status: Recover Clinical symptoms and latent days: Fever Clinical tests: Ultra-deep sequencing of the isolated viral genomic RNA(Illumina Novaseq 6000 platform) Discharge date: 2020.02.12
EPI_ISL_418991 Age: 62 Gender: M Occupation: NA Onset Date: \| Admission date: Travel history/ Contact history: Live in Wuhan Severity of illness: Severe Patient Status: Recover Clinical symptoms and latent days: Coughing Clinical tests: Ultra-deep sequencing of the isolated viral genomic RNA(Illumina Novaseq 6000 platform) Discharge date: 2020.03.15
MT263074 Age: NA Gender: NA Occupation: NA Onset Date: \| Admission date: Travel history/ Contact history: Contacted with an individual who had returned to Peru from travel to Italy. Clinical tests: Purified and amplified RNA;Reverse transcription;sequence-independent PCR amplification;NGS（Nextera XT kit,Illumina MiSeq sequencer)
MT635200 Age: NA Gender: NA Occupation: NA Onset Date: \| Admission date: Travel history/ Contact history: Without international travel Sources: Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States. Cell
MT635201 Age: NA Gender: NA Occupation: NA Onset Date: \| Admission date: Travel history/ Contact history: Without international travel Sources: Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States. Cell
MT635202 Age: NA Gender: NA Occupation: NA Onset Date: \| Admission date: Travel history/ Contact history: Without international travel Sources: Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States. Cell
MT635203 Age: NA Gender: NA Occupation: NA Onset Date: \| Admission date: Travel history/ Contact history: Without international travel Sources: Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States. Cell
MT635204 Age: NA Gender: NA Occupation: NA Onset Date: \| Admission date: Travel history/ Contact history: Without international travel Sources: Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States. Cell
MT635205 Age: NA Gender: NA Occupation: NA Onset Date: \| Admission date: Travel history/ Contact history: Without international travel Sources: Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States. Cell
MT635206 Age: NA Gender: NA Occupation: NA Onset Date: \| Admission date: Travel history/ Contact history: Without international travel Sources: Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States. Cell
MT635207 Age: NA Gender: NA Occupation: NA Onset Date: \| Admission date: Travel history/ Contact history: Without international travel Sources: Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States. Cell
MT635208 Age: NA Gender: NA Occupation: NA Onset Date: \| Admission date: Travel history/ Contact history: Without international travel Sources: Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States. Cell
MT372481 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Physiological and biochemical indicators: Nasopharyngeal swabs Sources: Complete Genome Sequences of SARS-CoV-2 Strains Detected in Malaysia. Microbiol Resour Announc
MT372480 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: Linked with a religious mass gathering Physiological and biochemical indicators: Nasopharyngeal swabs Sources: Complete Genome Sequences of SARS-CoV-2 Strains Detected in Malaysia. Microbiol Resour Announc
MT372483 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Travel history/ Contact history: A tourist coming back from Vietnam Physiological and biochemical indicators: Nasopharyngeal swabs Sources: Complete Genome Sequences of SARS-CoV-2 Strains Detected in Malaysia. Microbiol Resour Announc
MT372482 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Physiological and biochemical indicators: Nasopharyngeal swabs Sources: Complete Genome Sequences of SARS-CoV-2 Strains Detected in Malaysia. Microbiol Resour Announc
MT270101 Age: NA Gender: NA Occupation: NA Onset Date: 2020-01-23 \| Admission date: NA Travel history/ Contact history: Patient 1(MT270101): an employee who sat next to patient 0(no accession number,A Chinese resident who visited Germany) when attended a 1-h business meeting with patient 0 in a small room Clinical symptoms and latent days: On day of symptom onset: sore throat Further symptoms: cold-like symptoms, fatigue, chills, fever, cough, headache, joint pain, muscle pain, shortness of breath, and diarrhoea. latent days: 2-3(assumed 2·5) Physiological and biochemical indicators: nasopharyngeal and oropharyngeal swabs
MT270112 Age: NA Gender: NA Occupation: NA Onset Date: 2020-01-25 \| Admission date: Clinical symptoms and latent days: On day of symptom onset: cold-like symptoms and mild headache; Further symptoms: mild earache, chills, fatigue, mild sore throat, blocked nose, loose stool, and shortness of breath. latent days: 3–5(assumed 4) Physiological and biochemical indicators: nasopharyngeal and oropharyngeal swabs
MT270103 Age: NA Gender: NA Occupation: NA Onset Date: 2020-01-25 \| Admission date: Travel history/ Contact history: Patient 3(MT270103): worked simultaneously on the same computer for a short period of time with patient 1(MT270101) on Jan 24 Clinical symptoms and latent days: On day of symptom onset: fatigue, blocked nose, sinus congestion, headache and swollen lymph nodes; Further symptoms: chest pain, cough, and loose stool latent days: 1 Physiological and biochemical indicators: nasopharyngeal and oropharyngeal swabs
MT270102 Age: NA Gender: NA Occupation: NA Onset Date: 2020-01-24 \| Admission date: Travel history/ Contact history: Patient 4(MT270102): had contact with patient 0 on Jan 20, 21, and 22 Clinical symptoms and latent days: On day of symptom onset: chills; Further symptoms: fatigue, blocked nose, and sinus congestion; latent days: 2-4(assumed 4) Physiological and biochemical indicators: nasopharyngeal and oropharyngeal swabs
MT270105 Age: NA Gender: NA Occupation: NA Onset Date: 2020-01-24 \| Admission date: Travel history/ Contact history: Patient 5(MT270105): met patient 4(MT270102) on Jan 22 Clinical symptoms and latent days: On day of symptom onset: fever, limb pain, nausea, vomiting, cough, and fever; Further symptoms: fatigue, loss of appetite, and chest pain; latent days: 2 Physiological and biochemical indicators: nasopharyngeal and oropharyngeal swabs
MT270104 Age: NA Gender: NA Occupation: NA Onset Date: 2020-01-29 \| Admission date: Travel history/ Contact history: Patient 6(MT270104): a family member of patient5(MT270105) Clinical symptoms and latent days: Fever, vomiting, and nausea; latent days: NA Physiological and biochemical indicators: nasopharyngeal and oropharyngeal swabs
MT270106 Age: NA Gender: NA Occupation: NA Onset Date: 2020-01-28 \| Admission date: Travel history/ Contact history: Patient 7(MT270106): met patient 5(MT270105) for a 1.5h meeting with a distance of approximately 1.5 m on Jan 24 Clinical symptoms and latent days: On day of symptom onset: cough and blocked nose; Further symptoms: fatigue, headache, fever, nosebleed, and pneumonia; latent days: 4 Physiological and biochemical indicators: nasopharyngeal and oropharyngeal swabs
MT270107 Age: NA Gender: NA Occupation: NA Onset Date: 2020-01-28 \| Admission date: Travel history/ Contact history: Patient 8(MT270107): had regular daily meetings at work with patient 5(MT270105), including on Jan 22, 23, and 24. Clinical symptoms and latent days: On day of symptom onset: neck pain; Further symptoms: headache and fatigue; latent days: 4 Physiological and biochemical indicators: nasopharyngeal and oropharyngeal swabs
MT270108 Age: NA Gender: NA Occupation: NA Onset Date: 2020-01-31 \| Admission date: Travel history/ Contact history: Patient 9(MT270108): a family member of patient5(MT270105) Clinical symptoms and latent days: Fever, cough, vomiting, and diarrhoea; latent days: NA Physiological and biochemical indicators: nasopharyngeal and oropharyngeal swabs
MT270110 Age: NA Gender: NA Occupation: NA Onset Date: 2020-01-30 \| Admission date: Travel history/ Contact history: Patient 10(MT270110): had a 1h meeting with patient 7 and patient 16 Clinical symptoms and latent days: On day of symptom onset: shortness of breath; Further symptoms: cold-like-symptoms, night sweat, cough, and pneumonia; latent days: 2 Physiological and biochemical indicators: nasopharyngeal and oropharyngeal swabs
MT270109 Age: NA Gender: NA Occupation: NA Onset Date: 2020-01-27 \| Admission date: Travel history/ Contact history: Patient 11(MT270109): a family member of patient 5(MT270105) Clinical symptoms and latent days: Fever, limb pain, nausea, vomiting, back pain, and fatigue latent days: NA Physiological and biochemical indicators: nasopharyngeal and oropharyngeal swabs
MT270111 Age: NA Gender: NA Occupation: NA Onset Date: 2020-02-03 \| Admission date: Travel history/ Contact history: Patient 14(MT270111): a family member of patient 7(MT270106) Clinical symptoms and latent days: On day of symptom onset: fever; Further symptoms: mild cough, fatigue, mild headache, and loose stool latent days: 3-6(assumed 4·5) Physiological and biochemical indicators: nasopharyngeal and oropharyngeal swabs
MT270113 Age: NA Gender: NA Occupation: NA Onset Date: 2020-02-04 \| Admission date: Travel history/ Contact history: Patient 16: had a 1h meeting with patient 7(MT270106) and patient 10(MT270110) Clinical symptoms and latent days: Blocked nose latent days: 7 Physiological and biochemical indicators: nasopharyngeal and oropharyngeal swabs
EPI_ISL_428969 Age: NA Gender: NA Occupation: NA Onset Date: NA \| Admission date: NA Physiological and biochemical indicators: oro-pharyngeal swab Sources: Nursing homes and the elderly regarding the COVID-19 pandemic: situation report from Hungary. Geroscience
MT079843 Age: NA Gender: NA Occupation: NA Onset Date: 2020-01-14 \| Admission date: 2020-01-17 Severity of illness: Normal Patient Status: recover Clinical symptoms and latent days: all-body soreness, feverincubation period: 3 days Chronic Medical Illness: Thyroid nodules for more than 3 years and uterine fibroids for more than 10 years Clinical medication and treatment: Avelox, Arbidole, interferon Physiological and biochemical indicators: blood routine examination, ALT, AST, ALB, T-BIL, D-BIL, CREA, BUN, CK, myoglobin, LD Discharge date: 2020-02-06 Sources: Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China. Eur Respir J
MT079844 Age: NA Gender: NA Occupation: Nurse Onset Date: 2020-01-16 \| Admission date: 2020-01-19 Travel history/ Contact history: had close contact with a COVID-19 diagnosed patients Severity of illness: Normal Patient Status: recover Clinical symptoms and latent days: malaise, all-body soreness Chronic Medical Illness: 1. Postoperative thyroid papilloma in 2015; 2. after total thyroidectomy Physiological and biochemical indicators: blood routine examination, ALT, AST, ALB, T-BIL, D-BIL, CREA, BUN, CK, myoglobin, LD Discharge date: 2020-02-06 Sources: Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China. Eur Respir J
MT079845 Age: NA Gender: NA Occupation: Nurse Onset Date: 2020-01-13 \| Admission date: 2020-01-16 Travel history/ Contact history: took care of a COVID-19 diagnosed patients Severity of illness: Serious Patient Status: recover Clinical symptoms and latent days: throat weakness, fever half a day laterincubation period: 4 days Clinical medication and treatment: Avelox, Flucloxacillin, linezolid, Arbidole, interferon Physiological and biochemical indicators: blood routine examination, ALT, AST, ALB, T-BIL, D-BIL, CREA, BUN, CK, myoglobin, LD Discharge date: 2020-02-06 Sources: Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China. Eur Respir J
MT079846 Age: NA Gender: NA Occupation: Nurse Onset Date: 2020-01-15 \| Admission date: 2020-01-19 Travel history/ Contact history: had close contact with a COVID-19 diagnosed patients Severity of illness: Normal Patient Status: recover Clinical symptoms and latent days: sore throat, dry cough，slight headache Clinical medication and treatment: Avelox, Ceftriaxone, linezolid, Arbidole, interferon Physiological and biochemical indicators: blood routine examination, ALT, AST, ALB, T-BIL, D-BIL, CREA, BUN, CK, myoglobin, LD Discharge date: 2020-02-01 Sources: Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China. Eur Respir J
MT079847 Age: NA Gender: NA Occupation: Nurse Onset Date: 2020-01-09 \| Admission date: 2020-01-19 Travel history/ Contact history: took care of a COVID-19 diagnosed patients Severity of illness: Normal Patient Status: recover Clinical symptoms and latent days: slight malaise，dry coughincubation period: 4 days Chronic Medical Illness: 1. Thyroid cancer in 2017; 2. after total thyroidectomy Co-infection with other respiratory pathogens: co-infected with A/H1N1 influenza virus Clinical medication and treatment: Avelox, Oseltamivir Phosphate Granules, Arbidole, interferon Physiological and biochemical indicators: blood routine examination, ALT, AST, ALB, T-BIL, D-BIL, CREA, BUN, CK, myoglobin, LD Discharge date: 2020-02-03 Sources: Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China. Eur Respir J
MT079848 Age: NA Gender: NA Occupation: Nurse Onset Date: 2020-01-12 \| Admission date: 2020-01-16 Travel history/ Contact history: attended Neurosurgery department gala on Jan 12 Severity of illness: Normal Patient Status: recover Clinical symptoms and latent days: headache, malaise Clinical medication and treatment: Avelox, Ceftriaxone, linezolid, Oseltamivir Phosphate Granules, Arbidole, interferon Physiological and biochemical indicators: blood routine examination, ALT, AST, ALB, T-BIL, D-BIL, CREA, BUN, CK, myoglobin, LD Sources: Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China. Eur Respir J
MT079849 Age: NA Gender: NA Occupation: NA Onset Date: 2020-01-11 \| Admission date: 2020-01-18 Travel history/ Contact history: wasn’t exposed to colleagues and confirmed patients, but went to a fever clinic without a mask on about Jan 8. Severity of illness: Normal Patient Status: recover Clinical symptoms and latent days: fever Physiological and biochemical indicators: blood routine examination, ALT, AST, ALB, T-BIL, D-BIL, CREA, BUN, CK, myoglobin, LD Discharge date: 2020-01-30 Sources: Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China. Eur Respir J
MT079850 Age: NA Gender: NA Occupation: Nurse Onset Date: 2020-01-16 \| Admission date: 2020-01-19 Severity of illness: Normal Patient Status: recover Clinical symptoms and latent days: Itchy throat, sore throat Clinical medication and treatment: Ceftriaxone, Arbidole, interferon Physiological and biochemical indicators: blood routine examination, ALT, AST, ALB, T-BIL, D-BIL, CREA, BUN, CK, myoglobin, LD Discharge date: 2020-02-05 Sources: Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China. Eur Respir J
MT079851 Age: NA Gender: NA Occupation: Nurse Onset Date: 2020-01-08 \| Admission date: 2020-01-19 Severity of illness: Normal Patient Status: recover Clinical symptoms and latent days: sore throat, malaise, myalgia Physiological and biochemical indicators: blood routine examination, ALT, AST, ALB, T-BIL, D-BIL, CREA, BUN, CK, myoglobin, LD Discharge date: 20202/3 Sources: Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China. Eur Respir J
MT079852 Age: NA Gender: NA Occupation: Nurse in the Department of Cardiology Onset Date: 2020-01-12 \| Admission date: 2020-01-17 Travel history/ Contact history: had no clear exposure history Severity of illness: Serious Patient Status: recover Clinical symptoms and latent days: fever, malaise Chronic Medical Illness: Pituitary microadenoma for 2 years, oral bromocriptine for a long term Clinical medication and treatment: Avelox, Ceftriaxone, linezolid, tigecycline, voriconazole, Arbidole, Peramivir, interferon Physiological and biochemical indicators: blood routine examination, ALT, AST, ALB, T-BIL, D-BIL, CREA, BUN, CK, myoglobin, LD Discharge date: 2020-02-07 Sources: Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China. Eur Respir J
MT079853 Age: NA Gender: NA Occupation: NA Onset Date: 2020-01-19 \| Admission date: Patient is Severity of illness: Normal Patient Status: recover Clinical symptoms and latent days: fever incubation period: 3 days Physiological and biochemical indicators: blood routine examination, ALT, AST, ALB, T-BIL, D-BIL, CREA, BUN, CK, myoglobin, LD Discharge date: Patient is not hospi Sources: Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China. Eur Respir J
MT079854 Age: NA Gender: NA Occupation: Nurse in the Laboratory Department Onset Date: 2020-01-18 \| Admission date: Patient is Travel history/ Contact history: is responsible for the daily delivery clinical specimen of both inpatients and outpatients. Severity of illness: Normal Patient Status: recover Clinical symptoms and latent days: fever and have a cough Physiological and biochemical indicators: blood routine examination, ALT, AST, ALB, T-BIL, D-BIL, CREA, BUN, CK, myoglobin, LD Discharge date: Patient is not hospi Sources: Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China. Eur Respir J

RCoV19 - Clinical Records

Clinical Records